Found: 6
Select item for more details and to access through your institution.
Long term complete response of advanced hepatocellular carcinoma to glypican-3 specific chimeric antigen receptor T-Cells plus sorafenib, a case report.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.963031
- By:
- Publication type:
- Article
Targeting miR‐193a‐AML1‐ETO‐β‐catenin axis by melatonin suppresses the self‐renewal of leukaemia stem cells in leukaemia with t (8;21) translocation.
- Published in:
- Journal of Cellular & Molecular Medicine, 2019, v. 23, n. 8, p. 5246, doi. 10.1111/jcmm.14399
- By:
- Publication type:
- Article
Significance of alkaline Phosphatase After Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 12, p. 911, doi. 10.1016/j.clml.2023.08.017
- By:
- Publication type:
- Article
CT053, Anti-BCMA CAR T-cell therapy for Relapsed/Refractory Multiple Myeloma: Proof of Concept results from a Phase I Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e54, doi. 10.1016/j.clml.2019.09.083
- By:
- Publication type:
- Article
Down‐regulation of CD19 expression inhibits proliferation, adhesion, migration and invasion and promotes apoptosis and the efficacy of chemotherapeutic agents and imatinib in SUP‐B15 cells.
- Published in:
- Cell Biology International, 2018, v. 42, n. 9, p. 1228, doi. 10.1002/cbin.10994
- By:
- Publication type:
- Article
Prognostic significance of leukopenia during the induction phase in adult B cell acute lymphoblastic leukemia.
- Published in:
- Cancer Management & Research, 2018, v. 10, p. 625, doi. 10.2147/CMAR.S158359
- By:
- Publication type:
- Article